| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4219314 | Academic Radiology | 2010 | 6 Pages |
Abstract
This preclinical study suggests that MRI-FMT with fluorescent EGF provides excellent discrimination between tumors based on EGFR status. Reliable quantification of receptor status using minimally invasive techniques would be an important innovation for investigating new and existing cancer treatments that target these cellular mechanisms in research animals, and may be applied to identify receptor amplification in human brain cancer patients. This study represents the first systematic multianimal validation of receptor-specific imaging using MRI-guided fluorescence tomography.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Scott C. PhD, Kimberley S. PhD, Julia A. PhD, Summer L. PhD, Hannah L. Payne, P. Jack PhD, DVM, Keith D. PhD, Brian W. PhD,